Parasitic Ulcer Treatment Trial
Start Date
7/1/2024
Completion Date
7/1/2029
Summary
The Parasitic Ulcer Treatment Trial (PUTT) is a multi-center, parallel-group, randomized clinical trial. The purpose of this study is to determine whether including topical corticosteroids in a regimen for acanthamoeba keratitis (AK) will improve vision. Patients presenting to all enrollment centers with evidence of acanthamoeba keratitis will be eligible for the trial if there is evidence of ocular inflammation after 4 weeks of anti-amoebic therapy. Those who agree to participate will be randomized to one of two treatment groups: * Group 1: Topical corticosteroid * Group 2: Topical placebo
Eligibility Criteria
Age Range: 8 years to No maximum
Interventions
Polyhexamethylene biguanide (PHMB)
Topical corticosteroid
Topical placebo
Conditions
Locations
University of California, San Francisco
San Francisco, California 94158
United States
University of Colorado Anschutz
Aurora, Colorado 80045
United States
University of Florida
Gainesville, Florida 32605
United States
University of Miami
Miami, Florida 33136
United States
University of Illinois, Chicago
Chicago, Illinois 60612
United States
University of Iowa
Iowa City, Iowa 52242
United States
Johns Hopkins University
Baltimore, Maryland 21287
United States
Columbia University
New York, New York 10032
United States
Oregon Health and Science University
Portland, Oregon 97239
United States
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania 15219
United States
Baylor College of Medicine
Houston, Texas 77030
United States
University of Washington
Seattle, Washington 98104
United States
Federal University of São Paulo
São Paulo,
Brazil
Aravind Eye Hospital
Coimbatore, Tamil Nadu
India
Aravind Eye Hospital
Madurai, Tamil Nadu
India
Moorfields Eye Hospital
London,
United Kingdom